臨床試験の見通し

Can mouse models of cancer reliably improve clinical trial outcome?

Grit S Herter-Sprie & Kwok-Kin Wong

• 抽象的な

レビュー: 臨床試験の結果

Daclatasvir, an efficient inhibitor of the hepatitis C virus replication complex protein NS5A: review of virologic data, treatment ationale and clinical trials.

Stanislas Pol

• 抽象的な

研究の最新情報

Helping each other regulate clinical trials: a network of vaccine regulators from developing countries

Sergio A Nishioka, James Southern, Rolando Dominguez, Nora Dellepiane

• 抽象的な

レビュー: 臨床試験の結果

Future perspectives on the pharmacological management of depression

Sarah Yates, Eleanor Smith, Hamid A Alhaj, R Hamish McAllister-Williams

• 抽象的な

臨床試験の見通し

What should be the primary end point in irritable bowel syndrome?

Allen W Mangel

• 抽象的な

レビュー: 臨床試験の結果

New developments in the diagnosis and treatment of axial spondyloarthritis

Pedro Machado, Robert Landewe, Desiree van der Heijde

• 抽象的な

レビュー: 臨床試験の結果

Mesenchymal stem cells in neurological diseases

Ibrahim Kassis, Panayiota Petrou, Adi Vaknin-Dembinsky, Dimitrios Karussis

• 抽象的な